Evaluation of the effect of Shalomin on the treatment and improvement of symptoms in patients with Covid 19

Investigating the effect of oral and spray shalomine on the treatment and improvement of symptoms in patients with COVID19

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200725048199N1

Enrollment

146

Registered

2020-08-11

Start date

2020-08-10

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus disease (COVID-19). COVID-19, virus identified

Interventions

Intervention 1: The intervention group, in addition to receiving the approved treatment protocol for COVID19, uses Shalomin oral syrup (prepared from shallot extract) 10 cc every 6 hours and Shalomin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Positive coronavirus test willingness to participate in the study not receiving any medication other than the common COVID19 treatment protocol people who need to be hospitalized based on blood oxygen saturation and respiratory status.

Exclusion criteria

Exclusion criteria: Infection with other microbial or viral infections severe form of COVID19 disease inability to use syrup and respiratory spray Shalomin

Design outcomes

Primary

Measure	Time frame
Alteration of clinical and paraclinical symptoms of Covid 19 in patients. Timepoint: Once every three days after starting treatment until finally one month after starting treatment. Method of measurement: Based on vital signs and paraclinical information.;Corona virus test result. Timepoint: Two weeks after starting treatment. Method of measurement: Based on the results of corona virus polymerase chain reaction test.	—

Measure

Time frame

Alteration of clinical and paraclinical symptoms of Covid 19 in patients. Timepoint: Once every three days after starting treatment until finally one month after starting treatment. Method of measurement: Based on vital signs and paraclinical information.;Corona virus test result. Timepoint: Two weeks after starting treatment. Method of measurement: Based on the results of corona virus polymerase chain reaction test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmahnaz nosratabadi

Dezfoul University of Medical Sciences

nosratabadi.m@Dums.ac.ir+98 61 4242 3308

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026